InsidersTradesSigma
Follow the 博济医药 share price and the full directors' dealings record of the company, a listed issuer based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 博济医药 has published 5 insider filings. Market capitalisation: €3.6bn. The latest transaction was filed on 3 December 2025 (Sale). Among the most active insiders: 王廷春. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
博济医药 es una empresa especializada en el sector sanitario y farmacéutico, que cotiza en el mercado XSHE. Se centra en el desarrollo y la comercialización de medicamentos innovadores.